Appili Therapeutics Stock Forward View
| APLI Stock | CAD 0.01 -0.01 -25.00% |
The forecast reference data for Appili Therapeutics on this page is generated using Naive Prediction applied to historical price observations. Projected values and error measures are included as reference material.
The Naive Prediction forecasted value of Appili Therapeutics on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.0021 and the sum of the absolute errors of 0.13.This model is not at all useful as a medium-long range forecasting tool of Appili Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Appili Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights. The Naive Prediction reference values for Appili Therapeutics are derived from publicly available price data and should be used for informational purposes only. Naive Prediction Price Forecast For the 22nd of March
Given 90 days horizon, the Naive Prediction forecasted value of Appili Therapeutics on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.0021 , mean absolute percentage error of 0.0000059 , and the sum of the absolute errors of 0.13 .Please note that although there have been many attempts to predict Appili Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Appili Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Appili Therapeutics | Appili Therapeutics Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast for Appili Therapeutics focuses on identifying predictive downside and upside bands that can frame a realistic trading range. The projected forecast band currently runs from roughly 0.0001 on the downside to about 12.62 on the upside.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Appili Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Appili Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 107.9075 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0021 |
| MAPE | Mean absolute percentage error | 0.1037 |
| SAE | Sum of the absolute errors | 0.1296 |
Other Forecasting Options for Appili Therapeutics
Investors at all stages of experience who consider Appili must develop an understanding of Appili Therapeutics' price dynamics. The noise embedded in Appili Stock price charts can create misleading signals and skew investment decisions.Appili Therapeutics Related Equities
The following equities are related to Appili Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Appili Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Appili Therapeutics Market Strength Events
Market strength indicators applied to Appili Therapeutics stock give investors a structured view of the security's momentum relative to the overall market. Using these indicators, traders can refine their timing when entering or exiting positions in Appili Therapeutics.
| Rate Of Daily Change | 0.75 | |||
| Day Median Price | 0.015 | |||
| Day Typical Price | 0.015 | |||
| Price Action Indicator | -0.0025 | |||
| Period Momentum Indicator | -0.01 |
Appili Therapeutics Risk Indicators
Evaluating Appili Therapeutics' risk indicators is an important step in accurately forecasting its price and assessing the suitability of an investment. Understanding the risk profile of Appili Therapeutics' allows investors to make more informed decisions about position sizing and risk.
| Mean Deviation | 6.36 | |||
| Standard Deviation | 12.36 | |||
| Variance | 152.86 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Appili Therapeutics
Story coverage around Appili Therapeutics often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. A disciplined read of coverage separates durable relevance from temporary noise.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
Appili Therapeutics Short Properties
Reviewing short-oriented indicators for Appili Therapeutics is useful because long and short participants often create very different signals for timing and volatility. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 121.3 M | |
| Cash And Short Term Investments | 1.2 M |
More Resources for Appili Stock Analysis
Other Information on Investing in Appili Stock
Financial ratios for Appili Therapeutics organize key financial data into structured relationships. They reflect how financial results tie into valuation measures. This helps maintain uniform comparisons across financial reports.